| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Sanofi's insiders have accumulated 300,000 shares worth roughly $5.1M on balance. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
The largest recent buyer is Sanofi (10% Owner).
SNYNF sits in the Drug Manufacturers - General industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 494.8K | $43.10M | +300.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Sanofi | 10% Owner | Buy | 300,000 | $17.00 | $5,100,000.00 | +38.3% |